563 related articles for article (PubMed ID: 29566725)
21. Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease.
Chen DY; Lan JL; Lin FJ; Hsieh TY
J Rheumatol; 2004 Nov; 31(11):2189-98. PubMed ID: 15517632
[TBL] [Abstract][Full Text] [Related]
22. Serum Mac-2 binding protein glycosylation isomer and galectin-3 levels in adult-onset Still's disease and their association with cytokines.
Yoshida S; Koga T; Fujita Y; Yatsuhashi H; Matsumoto H; Sumichika Y; Saito K; Sato S; Asano T; Kobayakawa M; Ohira H; Mizokami M; Sugiyama M; Migita K
Front Immunol; 2024; 15():1385654. PubMed ID: 38711500
[TBL] [Abstract][Full Text] [Related]
23. Elevated plasma galectin-3 levels and their correlation with disease activity in adult-onset Still's disease.
Chen PK; Lan JL; Li JP; Chang CK; Chang SH; Huang PH; Yeo KJ; Chen DY
Clin Rheumatol; 2020 Jun; 39(6):1945-1952. PubMed ID: 31960208
[TBL] [Abstract][Full Text] [Related]
24. Serum S100A12 may be a useful biomarker of disease activity in adult-onset Still's disease.
Bae CB; Suh CH; An JM; Jung JY; Jeon JY; Nam JY; Kim HA
J Rheumatol; 2014 Dec; 41(12):2403-8. PubMed ID: 25274901
[TBL] [Abstract][Full Text] [Related]
25. Elevated high-mobility group B1 levels in active adult-onset Still's disease associated with systemic score and skin rash.
Jung JY; Suh CH; Sohn S; Nam JY; Kim HA
Clin Rheumatol; 2016 Aug; 35(8):1937-1942. PubMed ID: 27225247
[TBL] [Abstract][Full Text] [Related]
26. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
Kim HA; An JM; Nam JY; Jeon JY; Suh CH
J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
[TBL] [Abstract][Full Text] [Related]
27. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
[TBL] [Abstract][Full Text] [Related]
28. Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome.
Kasama T; Furuya H; Yanai R; Ohtsuka K; Takahashi R; Yajima N; Miwa Y; Kobayashi K
Clin Rheumatol; 2012 May; 31(5):853-60. PubMed ID: 22322207
[TBL] [Abstract][Full Text] [Related]
29. The potential role of advanced glycation end products (AGEs) and soluble receptors for AGEs (sRAGE) in the pathogenesis of adult-onset still's disease.
Chen DY; Chen YM; Lin CC; Hsieh CW; Wu YC; Hung WT; Chen HH; Lan JL
BMC Musculoskelet Disord; 2015 May; 16():111. PubMed ID: 25956266
[TBL] [Abstract][Full Text] [Related]
30. The levels of macrophage migration inhibitory factor as an indicator of disease activity and severity in adult-onset Still's disease.
Zou YQ; Lu LJ; Li SJ; Zeng T; Wang XD; Bao CD; Chen SL; Yang CD
Clin Biochem; 2008 May; 41(7-8):519-24. PubMed ID: 18261992
[TBL] [Abstract][Full Text] [Related]
31. Case Report: A Rare Case of Elderly-Onset Adult-Onset Still's Disease in a Patient With Systemic Lupus Erythematosus.
Hirooka Y; Okuda S; Sugiyama M; Shiga T; Nozaki Y; Kinoshita K; Funauchi M; Matsumura I
Front Immunol; 2022; 13():822169. PubMed ID: 35116046
[TBL] [Abstract][Full Text] [Related]
32. Dual effects of interleukin-10 on natural killer cells and monocytes and the implications for adult-onset Still's disease.
Aizaki Y; Yazawa H; Sato K; Mimura T
Clin Exp Rheumatol; 2021; 39 Suppl 132(5):22-29. PubMed ID: 34128808
[TBL] [Abstract][Full Text] [Related]
33. Involvement of TLR7 MyD88-dependent signaling pathway in the pathogenesis of adult-onset Still's disease.
Chen DY; Lin CC; Chen YM; Lan JL; Hung WT; Chen HH; Lai KL; Hsieh CW
Arthritis Res Ther; 2013 Mar; 15(2):R39. PubMed ID: 23497717
[TBL] [Abstract][Full Text] [Related]
34. Serum Interleukin-18 Provides a Clue to the Diagnosis of Adult-Onset Still's Disease: Findings from 6 Japanese Patients with Adult-Onset Still's Disease.
Ogita A; Ansai SI; Saeki H
J Nippon Med Sch; 2022 Mar; 89(1):114-118. PubMed ID: 34526450
[TBL] [Abstract][Full Text] [Related]
35. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis.
Tian R; Chen X; Yang C; Teng J; Qu H; Liu HL
Front Immunol; 2021; 12():654811. PubMed ID: 33868298
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
[TBL] [Abstract][Full Text] [Related]
37. Elevated Expression of the NLRP3 Inflammasome and Its Correlation with Disease Activity in Adult-onset Still Disease.
Hsieh CW; Chen YM; Lin CC; Tang KT; Chen HH; Hung WT; Lai KL; Chen DY
J Rheumatol; 2017 Aug; 44(8):1142-1150. PubMed ID: 28507179
[TBL] [Abstract][Full Text] [Related]
38. Association of CXCL10 and CXCL13 levels with disease activity and cutaneous manifestation in active adult-onset Still's disease.
Han JH; Suh CH; Jung JY; Nam JY; Kwon JE; Yim H; Kim HA
Arthritis Res Ther; 2015 Sep; 17(1):260. PubMed ID: 26385705
[TBL] [Abstract][Full Text] [Related]
39. Elevated Expression of C-Type Lectin Domain Family 5-Member A (CLEC5A) and Its Relation to Inflammatory Parameters and Disease Course in Adult-Onset Still's Disease.
Chen PK; Hsieh SL; Lan JL; Lin CC; Chang SH; Chen DY
J Immunol Res; 2020; 2020():9473497. PubMed ID: 32377540
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-18 Is a Potential Biomarker to Discriminate Active Adult-Onset Still's Disease From COVID-19.
Chen PK; Lan JL; Huang PH; Hsu JL; Chang CK; Tien N; Lin HJ; Chen DY
Front Immunol; 2021; 12():719544. PubMed ID: 34367188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
